1 Min Read
Oct 5 (Reuters) - Cytodyn Inc:
* Cytodyn receives orphan drug designation for PRO 140 for prevention of graft versus host disease Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.